Chemoinformaics analysis of 16-Octadecenoic acid, methyl ester
| Molecular Weight | 296.495 | nRot | 15 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 2 |
| Exact Molecular Weight | 296.272 | nRing | 0 |
| Solubility: LogS | -6.695 | nHRing | 0 |
| Solubility: LogP | 7.335 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.3385 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.204 |
| Synth | 2.1 |
| Natural Product Likeliness | 0.818 |
| NR-PPAR-gamma | 0.045 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.002 |
| HIA | 0.011 |
| CACO-2 | -4.805 |
| MDCK | 0.0000224 |
| BBB | 0.517 |
| PPB | 0.989419 |
| VDSS | 4.339 |
| FU | 0.0150271 |
| CYP1A2-inh | 0.532 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.434 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.243 |
| CYP2c9-sub | 0.964 |
| CYP2d6-inh | 0.431 |
| CYP2d6-sub | 0.093 |
| CYP3a4-inh | 0.479 |
| CYP3a4-sub | 0.063 |
| CL | 4.406 |
| T12 | 0.25 |
| hERG | 0.101 |
| Ames | 0.003 |
| ROA | 0.012 |
| SkinSen | 0.966 |
| Carcinogencity | 0.042 |
| EI | 0.967 |
| Respiratory | 0.873 |
| NR-Aromatase | 0.076 |
| Antiviral | No |
| Prediction | 0.615482 |